ESSENTIO MRI (Model L131); PROPONENT MRI (Model L231); ACCOLADE MRI (Model L331); ESSENTIO MRI (Models L110, L111); PRO
Boston Scientific · Decision date Oct 3, 2026
What did the FDA decide?
The FDA record P150012/S191 lists Boston Scientific as applicant for a 30-Day Notice supplement to PMA P150012, decided OK30 on 2026-10-03. The reported statement describes two manufacturing-related actions: implementing an additional acceptance activity for Accolade SL batteries and changing a specification for an existing Accolade EL battery specification. The device category is implantable pulse generator, pacemaker (non-CRT), product code LWP.
The action concerns battery acceptance and specification items, not a new approval of the whole system. The record does not identify which acceptance activity was added, what the revised EL specification is, or what validation data supported either change, so those details remain absent and the statement's purpose is not evidence of safety or clinical effectiveness.
FDA approval order statement
to implement an additional acceptance activity for Accolade SL batteries and to change a specification for an existing Accolade EL battery specification
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 3, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P150012/S191
- Regulatory pathway
- PMA supplement
- Applicant
- Boston Scientific
- Product code
- LWP
- Decision code
- OK30
- Decision date
- Oct 3, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Implantable pulse generator, pacemaker (non-CRT).
- Applicant
- Boston Scientific
- Product code
- LWP
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P150012. Subsequent supplements may change the device or its indications.
FDA decision timeline
P150012 · Original PMA
IMAGEREADY MR CONDITIONAL PACING SYSTEM AND INGEVITY PACE/SENSE LEAD
P150012/S191 received
Application receipt date recorded by FDA.
P150012/S191 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P150012. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P150012
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Boston Scientific | PMA approval | Apr 25, 2016 | FDA |
Explore the linked device profile
Other records with product code LWP
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic, Inc. | PMA supplement | Oct 29, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Oct 23, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Oct 5, 2026 | FDA | |
| Boston Scientific Corp | PMA supplement | Oct 3, 2026 | FDA | |
| Medtronic, Inc. | PMA approval | Aug 28, 2001 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Boston Scientific
- Headquarters
- Not reported
- Brand website
- bostonscientific.com
- FDA applicant address
- 4100 Hamline Ave. N, St Paul, MN, 55112
Sources and methodology
- Original FDA record: P150012/S191
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

